XML 47 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
September 30, 2013:
 
 
 
 
 
 
 
 
 
Net revenues
$
19,483

 
$
16,284

 
$

 
$
(3,799
)
 
$
31,968

Gross profit
1,294

 
4,884

 

 
(143
)
 
6,035

Operating profit (loss)(3)
1,012

 
1,471

 
(179
)
 
(143
)
 
2,161

September 30, 2012:
 

 
 

 
 

 
 

 
 

Net revenues
18,079

 
15,504

 

 
(3,356
)
 
30,227

Gross profit
1,081

 
4,672

 

 
(106
)
 
5,647

Operating profit (loss)
784

 
1,305

 
(169
)
 
(106
)
 
1,814

Nine Months Ended
 

 
 

 
 

 
 

 
 

September 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
56,593

 
48,474

 

 
(11,088
)
 
93,979

Gross profit
3,025

 
14,836

 

 
(409
)
 
17,452

Operating profit (loss)(3)
2,186

 
4,604

 
(553
)
 
(409
)
 
5,828

September 30, 2012:
 

 
 

 
 

 
 

 
 

Net revenues
54,802

 
47,373

 

 
(10,436
)
 
91,739

Gross profit
2,474

 
14,014

 

 
(279
)
 
16,209

Operating profit (loss)
1,644

 
4,071

 
(511
)
 
(279
)
 
4,925

Total assets:
 

 
 

 
 

 
 

 
 

September 30, 2013
37,274

 
30,048

 
1,679

 
(1,196
)
 
67,805

December 31, 2012
36,057

 
29,183

 
1,408

 
(736
)
 
65,912

Goodwill:
 

 
 

 
 

 
 

 
 

September 30, 2013
19,657

 
6,893

 

 

 
26,550

December 31, 2012
19,646

 
6,749

 

 

 
26,395


(1)          Net revenues of the Pharmacy Services Segment include approximately $1.9 billion and $2.0 billion of retail co-payments for the three months ended September 30, 2013 and 2012, respectively, as well as $6.1 billion and $6.4 billion of retail co-payments for the nine months ended September 30, 2013 and 2012, respectively.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $1.1 billion and $841 million for the three months ended September 30, 2013 and 2012, respectively, and $3.1 billion and $2.5 billion for the nine months ended September 30, 2013 and 2012 respectively; gross profit and operating profit of $143 million and $106 million for the three months ended September 30, 2013 and 2012, respectively, and $409 million and $279 million for the nine months ended September 30, 2013 and 2012, respectively.